Delivery Order SPE2DB20D9201-SPE2DB23FQRM2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,955.80 firm fixed-price delivery order is for the procurement of SKYLA 13.5 MG SYSTEMS, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the...
- The Defense Logistics Agency (DLA) has awarded a $2,824.56 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of SKYLA 13.5 MG SYSTEMS and is valid through October 18, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $23,537.50 firm fixed-price delivery order is for SKYLA 13.5 MG SYSTEMS and has an ultimate completion date of October 9, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,270.70 firm fixed-price delivery order is for the supply of SKYLA 13.5 MG SYSTEMS, a pharmaceutical product. The award is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valid...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,816.56 firm fixed-price delivery order is for the supply of SKYLA 13.5 MG SYSTEMS, a medical product. The award is associated with a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which enables the agency to issue delivery orders for a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,353.75 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of SKYLA 13.5 MG SYSTEMS, a specialized pharmaceutical product. This delivery order falls under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA, which enables the agency to issue delivery orders for a wide...
- This federal contract award, valued at $2,353.75, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the supply of SKYLA 13.5 MG SYSTEMS and does not have a set-aside designation. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,644.72 firm fixed-price delivery order is for the procurement of SKYLA 13.5 MG SYSTEMS, a specialized pharmaceutical product. The delivery order is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,353.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4566760104 SKYLA 13.5 MG SYSTEMS, a specialized pharmaceutical product, with a period of performance through January 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,209.10 firm fixed-price delivery order is for the provision of "SKYLA 13.5 MG SYSTEMS" medical products. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC enables...
- SPE2DB20D9201Indefinite Delivery Contract
- SPE2DB20D9201-SPE2DB23FQRM2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,718.48 firm fixed-price delivery order is for the supply of SKYLA 13.5 MG SYSTEMS, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a significant $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This contract covers branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain. The current delivery order does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 10/18/22 |